市場調查報告書
商品編碼
1466715
筆針市場:按產品、長度、應用、購買型態、銷售管道、最終用途 - 2024-2030 年全球預測Pen Needles Market by Product (Safety Pen Needles, Standard Pen Needles), Length (10mm, 12mm, 4mm), Application, Mode of Purchase, Sales Channel, End-Use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年筆用針頭市場規模為19億美元,預計2024年將達20.7億美元,2030年將達36億美元,複合年成長率為9.55%。
筆式針頭是患有糖尿病、生長激素缺乏症和其他荷爾蒙失衡等慢性病患者注射藥物的重要組成部分。這些細針專門設計用於筆式注射器,提供了一種方便、準確的方式,以微創方式注射精確劑量的藥物。糖尿病患者依賴定期注射胰島素來維持健康的血糖值。筆式針頭可與胰島素筆搭配使用,方便且準確地進行自我給藥,進而改善血糖控制和治療計畫的遵從性。推動筆針市場需求的主要因素之一是全球糖尿病盛行率的不斷上升。根據國際糖尿病聯盟(IDF)預測,有5.37億成年人(20-79歲)患有糖尿病,2030年將增加至6.43億,到2045年將增加至7.83億。其他影響成長的因素包括人們對適當糖尿病管理的認知不斷提高、政府鼓勵糖尿病患者進行自我監測的努力,以及新興市場對醫療設備的優惠報銷政策。更安全的筆針和超細針設計等創新使自行注射減輕了患者的痛苦並且更加有效。先進筆針技術的高價格可能會讓一些患者望而卻步,尤其是在獲得負擔得起的醫療保健機會有限的開發中國家。此外,缺乏對如何正確處置用過的針頭的認知是一個環境挑戰,因為處置不當可能導致針刺傷和感染疾病傳播。這些公司專注於創新和研究,以應對當前的挑戰,同時滿足不斷變化的消費者需求。主要發展中市場的公司正在取得重要進展,包括開發具有成本效益的製造程序、設計符合人體工學的改進筆以減少注射過程中的疼痛,以及探索替代材料和塗層以提高舒適度。
主要市場統計 | |
---|---|
基準年[2023] | 19億美元 |
預測年份 [2024] | 20.7億美元 |
預測年份 [2030] | 36億美元 |
複合年成長率(%) | 9.55% |
產品 增加安全筆針的使用,盡量減少針刺對病人的傷害
安全筆針具有安全機制,可防止針刺傷並降低感染風險。這些針頭通常由經常需要注射胰島素的糖尿病患者和醫療機構使用。安全筆針由於其易於使用、減輕疼痛和增強的安全功能而變得越來越受歡迎。對安全筆針的需求可以最大限度地減少處理用過的針頭時的意外刺傷,最終為醫護人員和患者創造一個更安全的環境。此外,這些針頭適合手部靈巧度有問題或難以操作標準筆針頭的人。標準筆針廣泛用於注射藥物,例如糖尿病管理中的胰島素注射、Glucagon-Like Peptide-1(GLP-1)促效劑和生長激素治療。有多種長度和規格可供選擇,可根據身體質量指數 (BMI)、注射部位選擇和個人偏好等因素滿足個人需求。標準筆針仍然很受歡迎,因為它們具有成本效益且廣泛使用,但必須嚴格遵守安全通訊協定。
長度:針長度:製造技術的進步允許更短的針長度以提高性能。
筆式針頭作為一種有效且方便的胰島素注射方法而受到歡迎。較短的針頭長度(例如 4 毫米、5 毫米和 6 毫米)適合兒童患者和體重指數 (BMI) 較低的成人。較短的長度大大減少了注射過程中的不適,同時仍允許將足夠的藥物劑量輸送到皮下層。此外,較短的針頭可能有利於那些經歷與注射相關的焦慮或恐懼的人,因為它可以減少與較長針頭尺寸相關的視覺影響和心理困擾。中間筆針尺寸類別包括 8 毫米,與較長的選擇相比,它結合了有效的藥物輸送和減少的不適,使其成為適合各種患者的多功能解決方案。 10 毫米和 12 毫米筆針被認為是較長的變體,通常由體脂較高且需要較高胰島素劑量的人使用。這些長度確保藥物有效到達皮下組織,並有助於最大限度地降低與肌肉注射相關的風險。
開發創新產品,擴大專業處方設備的型態
非處方藥筆針由消費者直接購買,無需醫療專業人員的處方箋。這種購買方法很受那些需要注射胰島素來控制糖尿病的人的歡迎,他們更喜歡比去醫療機構更容易獲得筆針用品。 OTC筆針有多種長度和規格可供選擇,以滿足不同使用者的需求。處方箋筆針頭必須經過有執照的醫療保健專業人員的核准,然後才能由藥劑師配發。這種購買方法使患者能夠接受有關正確使用筆針的適當指導,並獲得適合其個人需求和情況的建議。購買處方筆針頭通常需要製造商與保險公司或政府計劃合作,為因醫療狀況需要特定類型或尺寸的設備的患者提供負擔得起的選擇,並協商價格協議。
銷售管道:線上銷售管道因其具有競爭力的價格結構和廣泛的產品陣容而獲得支持
線下銷售管道是全球許多消費者購買筆用針頭的一級資訊來源。它由各種實體店組成,包括醫院、藥局、診所和零售店。儘管線上市場快速成長,但也存在有利於線下通路的因素。患有糖尿病等慢性疾病的患者通常需要持續諮詢醫療專業人員,他們可以指導他們使用胰島素注射技術,並根據他們的個人需求推薦合適的筆針。這種個人化的方法有助於建立患者對實體店的信任。有些患者喜歡能夠立即在實體店購買筆用針頭,因為他們可以在需要時購買所需數量的筆用針頭,而無需像網上購物那樣等待送貨。筆針的線上銷售管道因其便利性、有競爭力的價格和廣泛的產品可用性等優勢而越來越受歡迎。線上平台包括電子商務網站、線上藥局和製造商網站。消費者更喜歡線上管道主要是因為方便。線上零售商經常提供折扣和優惠,與線下管道相比,這使他們具有競爭優勢。此外,在一些實體店通路有限的地區,人們更有可能依賴線上平台來滿足筆針需求。
應用在微創皮膚手術中擴大使用筆針
Glucagon-Like Peptide-1 (GLP-1) 療法使用筆針注射 GLP-1 受體促效劑,以幫助控制第 2 型糖尿病患者的血糖值。筆式針頭易於使用,疼痛較少,並且可以精確劑量。生長激素 (GH) 缺乏症的治療採用重組人人體生長荷爾蒙(rhGH),需要每天皮下注射。筆針為此治療提供了有效的輸送系統,具有精確的劑量控制和提高治療方法的依從性。其緊湊的設計方便儲存和攜帶,適合兒童和成人生長遲緩患者的長期 GH 替代療法。近年來,筆針技術已被應用於毛髮再生治療,例如富血小板血漿(PRP)療法。 PRP 透過將濃縮血小板直接注射到頭皮中來促進血管生成和細胞增殖,從而刺激頭髮生長。筆針的精確性和易於穿透性使其成為這種微創手術的理想選擇,在毛髮生長方面具有良好的效果。筆式針頭因其易用性、攜帶性和胰島素注射的準確性而成為許多患者的選擇。佩恩針也用於微針手術,以實現活膚和減少疤痕。微針裝置在皮膚表層產生微小的孔,刺激膠原蛋白的產生並促進組織修復。筆針技術可確保在各種皮膚類型和狀況下獲得一致的結果,並允許在治療過程中精確控制針頭深度。
最終用途:在居家照護中採用一次性筆針
在家庭護理環境中,患有糖尿病和其他需要自行注射的疾病的患者更喜歡筆式針頭,因為它們易於使用、安全可靠。專為家庭使用而設計的筆式針頭通常具有細規格,以最大程度地減少注射過程中的疼痛,並配備有安全機制,例如可伸縮針頭,以預防事故。在醫院和診所,醫療保健專業人員在選擇筆針時優先考慮無菌、準確劑量和效率。一次性筆針的需求量很大,因為它們可以降低交叉污染和感染的風險。此外,醫療保健提供者更喜歡筆式針頭,因為其劑量準確、防錯機制以及與多個筆式注射器的兼容性以簡化工作流程。
區域洞察
美洲地區的特徵是人口中糖尿病患病率較高,其中美國憑藉其先進的醫療基礎設施和報銷設施佔據了筆針市場的很大佔有率。此外,美國糖尿病協會 (ADA) 等公共衛生組織已採取多項舉措,旨在提高人們對胰島素筆等糖尿病管理工具的認知。加拿大的需求也在增加,部分原因是主要企業開發的製造流程技術進步。由於其完善的醫療保健系統和監管良好的製藥行業,歐盟國家在全球筆用針頭市場中也發揮著重要作用。人們對糖尿病自我管理意識的提高以及生長激素治療藥物輸送技術的進步正在推動德國、法國和英國等國家採用注射筆針頭。此外,中東和非洲的市場成長主要是由糖尿病盛行率的增加和醫療保健系統的改善所推動的。沙烏地阿拉伯、南非和阿拉伯聯合大公國等國家正在投資致力於增強糖尿病管理解決方案的研究計畫。在亞太地區,由於中國、印度、日本、韓國、澳洲等國家糖尿病人口迅速增加,筆針市場成長潛力大。此外,醫療保健基礎設施的改善和更實惠使得先進的胰島素輸送設備(例如胰島素筆)得到了更多的採用。此外,旨在減輕糖尿病負擔的意識提高和政府措施預計也將推動該地區的市場成長。
FPNV定位矩陣
FPNV定位矩陣對於評估筆針市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對筆針市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.筆針市場的市場規模和預測是多少?
2.在筆針市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3. 筆針市場的技術趨勢和法規結構是什麼?
4.筆針市場主要廠商的市場佔有率為何?
5.進入筆針市場適合的型態和策略手段是什麼?
[197 Pages Report] The Pen Needles Market size was estimated at USD 1.90 billion in 2023 and expected to reach USD 2.07 billion in 2024, at a CAGR 9.55% to reach USD 3.60 billion by 2030.
Pen needles are an essential component in the administration of injectable medications for patients with chronic conditions such as diabetes, growth hormone deficiencies, and other hormonal imbalances. These fine-gauge needles are designed specifically for use with pen-style injection devices, offering a convenient and accurate method of delivering precise doses of medication in a minimally invasive manner. Individuals with diabetes rely on regular insulin injections to maintain healthy blood glucose levels. Using pen needles in combination with insulin pens allows for easy and accurate self-administration, helping to improve overall glycemic control and patient adherence to treatment regimens. One of the primary factors driving the need for the pen needles market is the increasing prevalence of diabetes worldwide. According to the International Diabetes Federation (IDF), 537 million adults (20-79 years) are living with diabetes, and is expected to rise to 643 million by 2030 and 783 million by 2045. Other factors influencing growth include increased awareness about proper diabetes management, government initiatives promoting self-monitoring practices among diabetics, and favorable reimbursement policies for medical devices in developed markets. Innovations such as safety-engineered pen needles and ultra-thin needle designs have made self-administration less painful and more effective for patients. The high cost of advanced pen needle technologies can be prohibitive for some patients, especially in developing countries where access to affordable healthcare is limited. In addition, a lack of awareness about proper disposal methods for used needles presents an environmental challenge, as improper disposal can lead to needle stick injuries and the spread of infections. Companies are focusing on innovation and research that addresses current challenges while catering to evolving consumer needs. Emerging players focus on key areas, including developing cost-effective manufacturing processes, designing ergonomically improved pens with reduced injection pain, and exploring alternative materials and coatings for enhanced comfort to enrich their business globally.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.90 billion |
Estimated Year [2024] | USD 2.07 billion |
Forecast Year [2030] | USD 3.60 billion |
CAGR (%) | 9.55% |
Product: Increasing use of safety pen needles for minimization of needlestick injuries amongst patients
Safety pen needles are designed with safety mechanisms to prevent needlestick injuries and reduce the risk of infection. These needles are commonly used in healthcare settings and by patients with diabetes who require frequent insulin injections. Safety pen needles have become increasingly popular due to their ease of use, reduced pain, and enhanced safety features. Need-based preference for safety pen needles stems from their ability to minimize accidental pricks while disposing of used needles, ultimately promoting a safer environment for both healthcare professionals and patients. Additionally, these needles cater to people with dexterity issues or those who have difficulty handling standard pen needles. Standard pen needles are widely used for insulin injections in diabetes management and other injectable medications such as glucagon-like peptide-1 (GLP-1) agonists or growth hormone treatments. They come in various lengths and gauges to suit individual needs based on factors such as body mass index (BMI), injection site choice, and personal preferences. Standard pen needles remain popular due to their cost-effectiveness and widespread availability, but need diligent adherence to safety protocols.
Length: Increasing advancements in manufacturing techniques to improve performance at smaller needle lengths
Pen needles have gained popularity as an effective and convenient method for insulin injections. Shorter pen needle lengths such as 4mm, 5mm, and 6mm cater to pediatric patients and adults with lower body mass indices (BMIs). The reduced length significantly diminishes discomfort during injection while delivering an appropriate medication dosage into the subcutaneous layer. Additionally, shorter needles can be advantageous for individuals who experience anxiety or fear related to injections by reducing the visual impact and psychological distress associated with longer needle sizes. The intermediate pen needle size category comprises the 8mm variant, a versatile solution for various patients by combining effective drug delivery with reduced discomfort compared to more extended options. The 10mm and 12mm pen needles are considered longer variants, typically utilized by those with higher body fat and requiring larger insulin doses. These lengths help ensure the medication reaches subcutaneous tissue effectively, minimizing any risk associated with intramuscular injections.
Mode of Purchase: Development of innovative products to extend access to specialized prescription devices
OTC pen needles are purchased directly by consumers without a prescription from a medical professional. This mode of purchase is popular for individuals who require insulin injections for diabetes management and prefer easy access to pen needle supplies over visiting a healthcare provider. OTC pen needles are available in various lengths and gauges to cater to different user needs. Prescription-based pen needles require a licensed healthcare professional's authorization before being dispensed by a pharmacist. This mode of purchase ensures that patients receive appropriate guidance on the correct use of pen needles, along with personalized advice based on individual needs and circumstances. Prescription pen needle purchases often involve collaboration between manufacturers and insurance companies or government programs, wherein pricing agreements are negotiated to provide affordable options for patients requiring specific types of devices or sizes due to their medical conditions.
Sales Channel: Online sales channel gaining traction with its competitive pricing structure and broader product offerings
The offline sales channel is a primary source of pen needles for many consumers worldwide. It comprises various brick-and-mortar outlets such as hospitals, pharmacies, clinics, and retail stores. Although the online market is growing rapidly, certain factors still contribute to the preference for offline channels. Patients with chronic illnesses such as diabetes often require continuous consultation with healthcare professionals, guiding them on insulin administration techniques and recommending appropriate pen needles based on individual needs. This personalized approach helps build trust among patients toward physical stores. Some patients prefer the immediate availability of products in physical stores since it allows them to purchase pen needles on an as-needed basis without waiting for delivery times associated with online orders. The online sales channel for pen needles has been gaining traction due to benefits such as convenience, competitive pricing, and broader product availability. Online platforms include e-commerce websites, online pharmacies, and manufacturer websites. Consumers prefer the online channel primarily for convenience because they can easily compare different products and prices to make informed decisions. Online retailers often offer discounts and deals that give them a competitive edge over offline channels. Furthermore, some areas with limited access to physical stores are more likely to rely on online platforms for their pen needle requirements.
Application: Rising utilization of pen needles for minimally invasive skin procedures
Glucagon-like peptide-1 (GLP-1) therapy involves the use of pen needles for the administration of GLP-1 receptor agonists, which help in managing blood sugar levels for patients with type 2 diabetes. The preference for pen needles in this application is due to their ease of use, minimal pain, and accurate dosage delivery. Growth hormone (GH) deficiency is treated using recombinant human growth hormone (rhGH), which requires daily subcutaneous injections. Pen needles offer an effective delivery system for this therapy due to their precise dosage control and improved adherence to the treatment regimen. Their compact design allows for convenient storage and transport, making them suitable for long-term GH replacement therapy in pediatric and adult patients with growth disorders. In recent years, pen needle technology has been adopted in hair restoration treatments such as platelet-rich plasma (PRP) therapy. PRP involves injecting concentrated platelets directly into the scalp to stimulate hair growth by enhancing angiogenesis and cellular proliferation. The accuracy and ease of penetration offered by pen needles make them an ideal choice for this minimally invasive procedure that provides promising results regarding hair regrowth. Insulin therapy is vital for managing diabetes, and pen needles are the preferred choice for many patients due to their ease of use, portability, and accuracy in insulin delivery. Pen needles are also used in microneedling procedures for skin rejuvenation and scar reduction. Microneedling devices create microscopic punctures in the skin's surface layer, triggering collagen production and promoting tissue repair. Pen needle technology offers precise control over needle depth during the treatment process, ensuring consistent results across various skin types and conditions.
End-Use: Employment of single-use disposable pen needles across homecare settings
In the homecare setting, patients with diabetes and other conditions requiring self-injection prefer pen needles that are easy to use, safe, and reliable. Pen needles designed for home use typically feature thin gauge sizes for minimal pain during injection, as well as safety mechanisms such as retractable needles to prevent accidental needlestick injuries. In hospitals and clinics, healthcare professionals prioritize sterility, accuracy in dosing, and efficiency when choosing pen needles. The demand for single-use disposable pen needles is high, as they reduce the risk of cross-contamination and infection. Additionally, healthcare providers prefer pen needles equipped with dose accuracy, error prevention mechanisms, and compatibility with multiple pen injectors to streamline their workflow.
Regional Insights
The Americas region is characterized by a high incidence of diabetes among its populace, where the United States holds a significant share of the pen needles market primarily due to advanced healthcare infrastructure and reimbursement facilities. Moreover, numerous initiatives taken by public health organizations such as the American Diabetes Association (ADA) aim at increasing awareness about diabetes management tools such as insulin pens. In Canada, too, there is an upward trend in demand, which can be attributed partly to technological advancements in manufacturing processes developed by established provincial players. EU countries also play a vital role in the global pen needles market, given their established healthcare systems and well-regulated pharmaceutical industries. Rising awareness about self-management of diabetes and advancements in drug delivery technologies for growth hormone therapy have led to higher adoption of pen needles in countries such as Germany, France, and the United Kingdom. Furthermore, market growth in the Middle East and Africa is primarily driven by an increased prevalence of diabetes and improving healthcare systems. Countries such as Saudi Arabia, South Africa, and the United Arab Emirates are investing in research initiatives focused on enhancing diabetes management solutions. In the Asia-Pacific region, there is significant potential for growth in the pen needles market due to rapidly increasing diabetic populations across countries such as China, India, Japan, South Korea, and Australia. Moreover, improving healthcare infrastructure along with enhanced affordability has led to greater adoption of advanced insulin delivery devices such as insulin pens. Furthermore, increased awareness and government initiatives aimed at reducing the burden of diabetes are also anticipated to spur market growth in this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pen Needles Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pen Needles Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pen Needles Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Advocate by Pharma Supply, Inc., Allison Medical, Inc., ARKRAY, Inc., Ayset Health Services, B. Braun SE, Becton, Dickinson and Company, Berpu Medical Technology Co., Ltd., Cardinal Health, Inc., F. Hoffmann-La Roche Ltd., Gan & Lee Pharmaceuticals Co., Ltd., GlucoRx Ltd., Hindustan Syringes & Medical Devices Ltd., IME-DC GmbH, Jiangsu Micsafe Medical Technology Co., Ltd., Jinan Babio Biotechnology Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Medexel Co., Ltd., Medical Technology and Devices S.p.A., MEDISEC Healthcare, Montmed Inc., Narang Medical Limited, Neon Diagnostics Ltd., Nipro Corporation, Novo Nordisk A/S, Owen Mumford Limited, Promisemed Medical Devices Inc., Shanghai Berpu Medical Co., Ltd, Shanghai Kindly Enterprise Development Group, Sol-Millennium, Spirit Healthcare Pty Ltd., Terumo Corporation, Trividia Health, Inc., UltiMed, Inc., Van Heek Medical, Vitrex Medical A/S, Vogt Medical Vertrieb GmbH, Ypsomed Holding AG, and Zibo Sunrise Medical Co., Ltd..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pen Needles Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pen Needles Market?
3. What are the technology trends and regulatory frameworks in the Pen Needles Market?
4. What is the market share of the leading vendors in the Pen Needles Market?
5. Which modes and strategic moves are suitable for entering the Pen Needles Market?